Prot#GR42691: A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients wit Neovascular Age-Related Macular Degeneration

Project: Research project

Project Details

StatusActive
Effective start/end date6/18/216/18/24

Funding

  • Genentech, Inc. (Prot#GR42691)